BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15885387)

  • 1. Tissue plasminogen activator expression in meningiomas and glioblastomas.
    Goh KY; Poon WS; Chan DT; Ip CP
    Clin Neurol Neurosurg; 2005 Jun; 107(4):296-300. PubMed ID: 15885387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A plasminogen regulation system in brain tumors].
    Kit OI; Frantsiyants EM; Kozlova LS; Rostorguev EE; Balyazin-Parfenov IV; Pogorelova YA
    Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(2):22-27. PubMed ID: 28524122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isozymes of pyruvate kinase from human brain, meningiomas, and malignant gliomas.
    van Veelen CW; Verbiest H; Vlug AM; Rijksen G; Staal GE
    Cancer Res; 1978 Dec; 38(12):4681-7. PubMed ID: 214230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
    Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
    Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Localization of platelet-derived endothelial cell growth factor in human glioblastoma and meningioma].
    Nakayama Y; Sueishi K; Fukushima T; Oka K; Tomonaga M
    Noshuyo Byori; 1994; 11(2):187-91. PubMed ID: 7894624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The fibrinolytic tissue activity of various brain tumors].
    Hindersin P; Koch K
    Psychiatr Neurol Med Psychol (Leipz); 1990 Feb; 42(2):79-84. PubMed ID: 2158115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI findings of intracranial cystic meningiomas.
    Zhang D; Hu LB; Zhen JW; Zou LG; Feng XY; Wang WX; Wen L
    Clin Radiol; 2009 Aug; 64(8):792-800. PubMed ID: 19589418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue.
    Petersen G; Moesgaard B; Schmid PC; Schmid HH; Broholm H; Kosteljanetz M; Hansen HS
    J Neurochem; 2005 Apr; 93(2):299-309. PubMed ID: 15816853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological significance of tissue plasminogen activator content in brain tumors.
    Sawaya R; Rämö OJ; Shi ML; Mandybur G
    J Neurosurg; 1991 Mar; 74(3):480-6. PubMed ID: 1899696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SP100 reduces malignancy of human glioma cells.
    Held-Feindt J; Hattermann K; Knerlich-Lukoschus F; Mehdorn HM; Mentlein R
    Int J Oncol; 2011 Apr; 38(4):1023-30. PubMed ID: 21274506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningiomas, dicentric chromosomes, gliomas, and telomerase activity.
    Carroll T; Maltby E; Brock I; Royds J; Timperley W; Jellinek D
    J Pathol; 1999 Aug; 188(4):395-9. PubMed ID: 10440750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.
    Falchetti ML; Pallini R; Larocca LM; Verna R; D'Ambrosio E
    J Clin Pathol; 1999 Mar; 52(3):234-6. PubMed ID: 10450187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.
    Cheng LL; Chang IW; Louis DN; Gonzalez RG
    Cancer Res; 1998 May; 58(9):1825-32. PubMed ID: 9581820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
    Maes L; Van Neste L; Van Damme K; Kalala JP; De Ridder L; Bekaert S; Cornelissen M
    Oncol Rep; 2007 Dec; 18(6):1571-6. PubMed ID: 17982646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of SPARC expression and basement membrane intactness at the tumour-brain border of invasive meningiomas.
    Schittenhelm J; Mittelbronn M; Roser F; Tatagiba M; Mawrin C; Bornemann A
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):525-31. PubMed ID: 16972886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis and angiogenesis in glioblastomas and grade 1 meningiomas.
    Principi M; Italiani M; Guiducci A; Aprile I; Muti M; Giulianelli G; Ottaviano P
    Neuroradiology; 2003 Apr; 45(4):205-11. PubMed ID: 12687302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma.
    Onguru O; Gamsizkan M; Ulutin C; Gunhan O
    Neuropathology; 2008 Feb; 28(1):29-34. PubMed ID: 18181832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas.
    Ding YS; Wang HD; Tang K; Hu ZG; Jin W; Yan W
    Ann Clin Lab Sci; 2008; 38(4):344-51. PubMed ID: 18988927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AgNOR expression in CNS neoplasms.
    Husain N; Bagchi M; Husain M; Tiwari B
    Indian J Pathol Microbiol; 1997 Oct; 40(4):503-9. PubMed ID: 9444862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of alkaline phosphatase activity predicts meningioma recurrence.
    Bouvier C; Liprandi A; Colin C; Giorgi R; Quilichini B; Metellus P; Figarella-Branger D
    Am J Clin Pathol; 2005 Aug; 124(2):252-8. PubMed ID: 16040297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.